Riestra AC - Search Results

1

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations.

Fuentes-Irigoyen R, Martín de Rosales Cabrera AM, Riestra AC, Vila MN, Dávila-Pousa C, Alonso Herreros JM, López-Cabezas C, Cañete C, Pernía-López MS, Garcia-Palomo M, Arriola Villalobos P, Ibares-Frías L, Urcelay Segura JL, Yañez Martínez JR. Fuentes-Irigoyen R, et al. Among authors: riestra ac. Farm Hosp. 2018 Mar 1;42(2):82-88. doi: 10.7399/fh.10943. Farm Hosp. 2018. PMID: 29501060 English.

2

Platelet rich plasma in ocular surface.

Riestra AC, Alonso-Herreros JM, Merayo-Lloves J. Riestra AC, et al. Arch Soc Esp Oftalmol. 2016 Oct;91(10):475-90. doi: 10.1016/j.oftal.2016.03.001. Epub 2016 Apr 6. Arch Soc Esp Oftalmol. 2016. PMID: 27062018 Review. English, Spanish.

3

Robotic chemotherapy compounding: A multicenter productivity approach.

Riestra AC, López-Cabezas C, Jobard M, Campo M, Tamés MJ, Marín AM, Brandely-Piat ML, Carcelero-San Martín E, Batista R, Cajaraville G. Riestra AC, et al. J Oncol Pharm Pract. 2022 Mar;28(2):362-372. doi: 10.1177/1078155221992841. Epub 2021 Feb 11. J Oncol Pharm Pract. 2022. PMID: 33573462

4

Galenic validation of plasma rich in growth factors eye drops.

Anitua E, Muruzábal F, Riestra A, De la Fuente M, Merayo-Lloves J. Anitua E, et al. Farm Hosp. 2019 Mar 1;43(2):45-49. doi: 10.7399/fh.11106. Farm Hosp. 2019. PMID: 30848175 English.

5

Effects of new biomimetic regenerating agents on corneal wound healing in an experimental model of post-surgical corneal ulcers.

Alcalde I, Íñigo-Portugués A, Carreño N, Riestra AC, Merayo-Lloves JM. Alcalde I, et al. Among authors: riestra ac. Arch Soc Esp Oftalmol. 2015 Oct;90(10):467-74. doi: 10.1016/j.oftal.2015.04.006. Epub 2015 Jun 20. Arch Soc Esp Oftalmol. 2015. PMID: 26101128 English, Spanish.

6

Polymeric nanocapsules: a potential new therapy for corneal wound healing.

Reimondez-Troitiño S, Alcalde I, Csaba N, Íñigo-Portugués A, de la Fuente M, Bech F, Riestra AC, Merayo-Lloves J, Alonso MJ. Reimondez-Troitiño S, et al. Among authors: riestra ac. Drug Deliv Transl Res. 2016 Dec;6(6):708-721. doi: 10.1007/s13346-016-0312-0. Drug Deliv Transl Res. 2016. PMID: 27392604

7

Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.

Anitua E, de la Fuente M, Muruzabal F, Riestra A, Merayo-Lloves J, Orive G. Anitua E, et al. Exp Eye Res. 2015 Jun;135:118-26. doi: 10.1016/j.exer.2015.02.016. Epub 2015 Feb 21. Exp Eye Res. 2015. PMID: 25708868

8

The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome.

Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Anitua E, Muruzabal F, Orive G, Fernández-Vega L. Sanchez-Avila RM, et al. Among authors: riestra ac. J Ocul Pharmacol Ther. 2017 Jun;33(5):391-399. doi: 10.1089/jop.2016.0166. Epub 2017 Apr 4. J Ocul Pharmacol Ther. 2017. PMID: 28375790

9

PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.

Anitua E, Muruzabal F, de la Fuente M, Riestra A, Merayo-Lloves J, Orive G. Anitua E, et al. Exp Eye Res. 2016 Oct;151:115-21. doi: 10.1016/j.exer.2016.08.012. Epub 2016 Aug 25. Exp Eye Res. 2016. PMID: 27567559 Review.

10

Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Fernandez-Vega Cueto L, Anitua E, Begoña L, Muruzabal F, Orive G. Sanchez-Avila RM, et al. Among authors: riestra ac. Int Ophthalmol. 2018 Jun;38(3):1193-1204. doi: 10.1007/s10792-017-0582-7. Epub 2017 Jun 15. Int Ophthalmol. 2018. PMID: 28620707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page